Literature DB >> 6604114

Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities.

O Narayan, S Herzog, K Frese, H Scheefers, R Rott.   

Abstract

Borna disease virus is an unclassified agent that causes a rare but fatal encephalitis in horses in Germany. In experimental animals the virus causes acute fatal encephalitis in some instances and chronic encephalitis with abnormal behavior in others. In initial studies of the pathogenesis of the latter disease in rats, the virus was shown to replicate only in the nervous system, with the greatest concentration of infectivity in the cerebrum and eyes. Viral replication continued indefinitely in both newborn and adult rats. The adult animals developed self-limiting, necrotizing encephalitis in the cerebrum, with inflammation spreading to the retina. Inflammation receded after two months, however, with concomitant cessation of necrosis; static hydrocephalus was observed at this point. Levels of viral replication were unaffected by these changes. Rats became frenzied and aggressive during the encephalitic period but became permanently passive and inactive after inflammation receded. Infected neonates and immunosuppressed adults did not become ill. The frenzied behavior and subsequent blindness in immunocompetent adults were therefore attributed to a uniquely transient immunopathologic reaction targeted to centers in the limbic system and retinal neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604114     DOI: 10.1093/infdis/148.2.305

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Preventive effects of early anti-CD4 or anti-CD8 treatment on Borna disease in rats.

Authors:  L Stitz; M Sobbe; T Bilzer
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 2.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Atypical dissemination of the highly neurotropic Borna disease virus during persistent infection in cyclosporine A-treated, immunosuppressed rats.

Authors:  L Stitz; D Schilken; K Frese
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

4.  Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology.

Authors:  W Hallensleben; M Schwemmle; J Hausmann; L Stitz; B Volk; A Pagenstecher; P Staeheli
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Virus-specific CD4+ T cells eliminate borna disease virus from the brain via induction of cytotoxic CD8+ T cells.

Authors:  K Nöske; T Bilzer; O Planz; L Stitz
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Animal models of CNS viral disease: examples from borna disease virus models.

Authors:  Marylou V Solbrig
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-24

7. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

8.  Enhanced neurovirulence of borna disease virus variants associated with nucleotide changes in the glycoprotein and L polymerase genes.

Authors:  Yoshii Nishino; Darwyn Kobasa; Steven A Rubin; Mikhail V Pletnikov; Kathryn M Carbone
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein.

Authors:  Guiqing Peng; Yan Yan; Chengliang Zhu; Shiqun Wang; Xiaohong Yan; Lili Lu; Wei Li; Jing Hu; Wei Wei; Yongxin Mu; Yanni Chen; Yong Feng; Rui Gong; Kailang Wu; Fengmin Zhang; Xiaolian Zhang; Ying Zhu; Jianguo Wu
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  A mutation in Myo15 leads to Usher-like symptoms in LEW/Ztm-ci2 rats.

Authors:  Nadine Held; Bart M G Smits; Roland Gockeln; Stephanie Schubert; Heike Nave; Emily Northrup; Edwin Cuppen; Hans J Hedrich; Dirk Wedekind
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.